Rockwell Medical surges on drug data

optionMONSTER

Successful Late-Stage Trial

Rockwell Medical announced that its SFP kidney drug successfully and safely delivered iron in dialysis patients, according to a phase 3 study. It also showed no anaphylactic or hypersensitivity events or increase in hypotension or infection. RMTI surges 20 percent before the opening bell on my tradeMONSTER platform.

Accreditation News Lifts Apollo Group

Apollo Group announced the accreditation of its flagship University of Phoenix was renewed. The decision covers the next decade and is a relief for the company after it had been placed on notice for two years over the school's governance. APOL climbs 7 percent on the news.

Texas Industries Beats as Construction Improves

Texas Industries reported fourth-quarter revenue of $213.5 million, while analysts had only expected $199.7 million. Management also said construction activity continues to improve. TXI climbs almost 5 percent in the premarket.



More From optionMONSTER
View Comments (0)